393 related articles for article (PubMed ID: 2449958)
21. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
Klinger HP; Shows TB
J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
[TBL] [Abstract][Full Text] [Related]
22. Chromosome alterations in Syrian hamster cells transformed in vitro by sodium bisulfite, a nonclastogenic carcinogen.
Popescu NC; DiPaolo JA
Cancer Res; 1988 Dec; 48(24 Pt 1):7246-51. PubMed ID: 3191496
[TBL] [Abstract][Full Text] [Related]
23. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
Benedict WF; Weissman BE; Mark C; Stanbridge EJ
Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
[TBL] [Abstract][Full Text] [Related]
24. Modification of myc gene amplification in human somatic cell hybrids.
Iman DS; Shay JW
Cancer Res; 1989 Aug; 49(16):4417-22. PubMed ID: 2568170
[TBL] [Abstract][Full Text] [Related]
25. Oncogene-mediated transformation of fetal rat colon in vitro.
Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
[TBL] [Abstract][Full Text] [Related]
26. Activated fos oncogene in rat embryo fibroblasts transformed by ras and myc oncogenes.
Denner J; Jandrig B; Spitkovsky DD; Ehm I; Kisselyov FL; Schramm T
Neoplasma; 1988; 35(3):263-70. PubMed ID: 3405335
[TBL] [Abstract][Full Text] [Related]
27. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
28. PA-1, a human cell model for multistage carcinogenesis: oncogenes and other factors.
Tainsky MA; Krizman DB; Chiao PJ; Yim SO; Giovanella BC
Anticancer Res; 1988; 8(5A):899-913. PubMed ID: 3052262
[TBL] [Abstract][Full Text] [Related]
29. Oncogene-mediated multistep transformation of C3H10T1/2 cells.
Taparowsky EJ; Heaney ML; Parsons JT
Cancer Res; 1987 Aug; 47(15):4125-9. PubMed ID: 3300959
[TBL] [Abstract][Full Text] [Related]
30. Escape from senescence in hybrid cell clones involves deletions of two regions located on human chromosome 1q.
Karlsson C; Stenman G; Vojta PJ; Bongcam-Rudloff E; Barrett JC; Westermark B; Paulsson Y
Cancer Res; 1996 Jan; 56(2):241-5. PubMed ID: 8542573
[TBL] [Abstract][Full Text] [Related]
31. Tissue-specific expression, evolutionary conservation and localization of the cph proto-oncogene on Syrian hamster chromosome X.
Velasco JA; Zimonjic DB; Popescu NC; Cansado J; DiPaolo JA; Albor A; Notario V
Oncogene; 1996 Jun; 12(12):2713-7. PubMed ID: 8700531
[TBL] [Abstract][Full Text] [Related]
32. Transformation of normal homologous cells by a spontaneously activated Ha-ras oncogene.
Schwartz SA; Shuler CF; Freebeck P
Cancer Res; 1988 Jun; 48(12):3470-7. PubMed ID: 3285996
[TBL] [Abstract][Full Text] [Related]
33. Oncogene transformation frequency of nonsenescent SFME cells is increased by c-myc.
Rawson C; Shirahata S; Collodi P; Natsuno T; Barnes D
Oncogene; 1991 Mar; 6(3):487-9. PubMed ID: 2011405
[TBL] [Abstract][Full Text] [Related]
34. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
35. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
36. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
[TBL] [Abstract][Full Text] [Related]
37. Tumor progression following transformation of murine monocytes by v-myc: acquisition of immortalization and tumorigenicity.
Stapleton P; Takayama Y; Hartshorn A; Kalaizis A; Rowe PB; Symonds G
Oncogene; 1991 May; 6(5):807-17. PubMed ID: 1711191
[TBL] [Abstract][Full Text] [Related]
38. V-Ha-ras-dependent expression of interleukin-3 mRNA in premalignant PB-3c mast cells correlates with the formation of tumors without interleukin-3 gene rearrangements.
Aebersold DM; Banholzer R; Backenstoss V; Hirsch HH; Moroni C
Exp Hematol; 1997 May; 25(5):395-404. PubMed ID: 9168061
[TBL] [Abstract][Full Text] [Related]
39. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
[TBL] [Abstract][Full Text] [Related]
40. Nonrandom chromosomal alterations in nickel-transformed Chinese hamster embryo cells.
Conway K; Costa M
Cancer Res; 1989 Nov; 49(21):6032-8. PubMed ID: 2790817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
